Registered entities
Sangamo Biosciences Inc.
Reg. No. 680359556United States
SANGAMO BIOSCIENCES INC
Reg. No. 1001233United States
SANGAMO THERAPEUTICS UK LTD
Reg. No. 3756817Germany
Innovation
159 patent families (118 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 49,338 times.
| Year | Filings |
|---|---|
| 2014 | 62 |
| 2015 | 74 |
| 2016 | 73 |
| 2017 | 66 |
| 2018 | 41 |
| 2019 | 31 |
| 2020 | 25 |
| 2021 | 25 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 4 |
| 2025 | 3 |
Investor mix
5 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 4 | 80% |